增加LACTB2表达调节氧化酸化和mTORC1信号的结肠直肠癌
Hui Li1, Jia-Ying Wen2, Cui-Zhen Liu3
1Department of Colorectal and Anal Surgery, The First Affiliated Hospital of Guangxi Medical University, Shuangyong RD 6, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Molecular biotechnology
|April 25, 2024
概括
乳酸β2 (LACTB2) 在结直肠癌 (CRC) 中表达高,促进瘤生长. 这项研究揭示了LACTB2的存在.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 结肠直肠癌 (CRC) 仍然是一个重大的全球健康挑战.
- 了解驱动CRC进展的分子机制对于开发有效疗法至关重要.
研究的目的:
- 研究乳酸β2 (LACTB2) 在结直肠癌 (CRC) 中的作用和机制.
- 为了确定CRC治疗的潜在治疗点和化合物.
主要方法:
- 对大型基因表达数据集 (UCSC Xena,GTEx,GEO,TCGA) 的分析.
- 免疫组织化学用于蛋白质表达的验证.
- 生物信息分析包括CIBERSORT,GSEA,KEGG和GO.
- 通过HERB数据库和分子对接模拟进行药物选.
主要成果:
- 与非癌样本相比,LACTB2在CRC组织中显著上调.
- 高LACTB2表达与较低的B细胞透相关.
- LACTB2和相关基因与DNA合成/修复,线粒体功能和mTORC1信号传递有关.
- 奎尔西通过分子对接显示了针对LACTB2的潜力.
结论:
- 在结直肠癌中,LACTB2是一种新型的瘤基因.
- LACTB2促进结直肠瘤的产生和进展.
- LACTB2可以作为CRC的潜在治疗点.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Electron Transport Chain: Complex I and II
13.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.1K


